Skip to content

Research of Intelligent Assessment of Coronary Artery High-Risk Plaques

Research of Intelligent Assessment of Coronary Artery High-Risk Plaques

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093438
Enrollment
Unknown
Registered
2024-12-05
Start date
2024-12-15
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

Observation group:None

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Clinically suspected or definite diagnosis of coronary heart disease; 2.Age >=18 years and <= 80 years; 3. Investigators assessed suspected coronary stenosis. 4. The CCTA image is clear and readable, and the CCTA inspection should be performed on a machine with at least 64 detector rows; 5. Complete the CCTA examination and the OCT examination within 3 months, and the image data of the above two examinations are complete and clear. 6.There were no changes in therapeutic agents or clinical symptoms between OCT and CCTA. 7. If the patient also has CTP and FFR data, it should also be collected and stored.

Exclusion criteria

Exclusion criteria: 1. Pregnant women, breastfeeding women or women planning pregnancy. 2.History of myocardial infarction within 30 days prior to CCTA. 3. Previous coronary CABG, pacemaker implantation, ICD, artificial valve; The presence of severe calcification or stenting in the lesion affected lumen and lesion evaluation. 4.Subjects were assessed by the investigator to have other conditions that made them unsuitable for study participation. 5.OCT or CCTA images are of poor quality and difficult to accurately evaluate. 6.It is difficult to register OCT and CCTA image data. 7. OCT is performed after PCI or pre-dilation of the target lesion.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events;

Countries

China

Contacts

Public ContactWang Yining

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

yiningpumc@163.com+86 136 6100 3076

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026